InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Flowers Kirsten, Directeur Commercial. Officer active across 2 companies, notably Kura Oncology, Inc.. In total, 4 disclosures have been recorded. Split: 1 buy · 1 sell. Total volume traded: €24k. History available since 26 January 2022. The latest transaction was disclosed on 27 January 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Flowers Kirsten
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
13,513 shares@ €1.166250.0% of flowCommon StockSEC:0001062993-23-003492:0
Canonical exit: 4 Apr 2023 (T+90)
1,906 shares@ US$13.89100.0% of flowCommon StockSEC:0001209191-23-005748:0
13,513 shares@ €1.166250.0% of flowCommon StockSEC:0001062993-23-000607:0
21,900 shares0Common StockSEC:0001209191-22-005374:0
4 of 4 declarations
About Flowers Kirsten
Kirsten Flowers is the Chief Commercial Officer at Kura Oncology, Inc. In this role, she oversees business operations and is responsible for the company's business development strategy. Flowers plays a key role in developing and implementing strategies that strengthen Kura Oncology's position in the market. Her expertise in business development is essential to support the company's growth.
